This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Physicians’ Education Resource®, LLC, and Pharmacy Times Continuing Education. Physicians’ Education Resource®, LLC, is accredited by the ACCME to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 24.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for 21.75 contact hours (2.175 CEUs) under the ACPE universal activity numbers:
Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 24.25 Contact Hours.
Acknowledgment of Commercial Support
This activity is supported by educational grants from AbbVie Inc.; AstraZeneca; Athenex; Celgene Corporation; Daiichi Sankyo, Inc.; Eisai; Exelixis, Inc.; Genomic Health; Incyte Corporation; MacroGenics, Inc.; Novartis Pharmaceuticals Corporation; Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Pfizer; Regeneron; Sanofi Genzyme; Seattle Genetics, Inc.; and Taiho Oncology, Inc.
37th Annual CFS®: Innovative Cancer Therapy for Tomorrow
You must be logged in and registered to this meeting to access the e-Syllabus for this conference.
Click here to log into GoToPER.com